Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMc Mining Regulatory News (MCM)

Share Price Information for Mc Mining (MCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.60
Bid: 7.20
Ask: 8.00
Change: 0.00 (0.00%)
Spread: 0.80 (11.111%)
Open: 7.60
High: 7.60
Low: 7.60
Prev. Close: 7.60
MCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appendix 5B

30 Oct 2020 07:00

RNS Number : 6832D
MC Mining Limited
30 October 2020
 

Appendix 5B

Mining exploration entity or oil and gas exploration entityquarterly cash flow report

Name of entity

MC Mining Limited

ABN

 

Quarter ended ("current quarter")

98 008 905 388

30 September 2020

 

Consolidated statement of cash flows

Current quarterUSD'000

Year to date (three months)USD'000

1.

Cash flows from operating activities

3,973

3,973

1.1

Receipts from customers

1.2

Payments for

(a) exploration & evaluation

(b) development

(c) production

(3,974)

(3,974)

(d) staff costs

(430)

(430)

(e) administration and corporate costs

(801)

(801)

1.3

Dividends received (see note 3)

1.4

Interest received

-

-

1.5

Interest and other costs of finance paid

(12)

(12)

1.6

Income taxes paid

1.7

Government grants and tax incentives

1.8

Other (provide details if material)

10

10

1.9

Net cash from / (used in) operating activities

(1,234)

(1,234)

2.

Cash flows from investing activities

2.1

Payments to acquire or for:

(a) entities

(b) tenements

(c) property, plant and equipment

(39)

(39)

(d) exploration & evaluation

(10)

(10)

(e) investments

(104)

(104)

(f) other non-current assets

2.2

Proceeds from the disposal of:

(a) entities

(b) tenements

(c) property, plant and equipment

510

510

(d) investments

(e) other non-current assets

2.3

Cash flows from loans to other entities

2.4

Dividends received (see note 3)

2.5

Other (provide details if material)

(62)

(62)

2.6

Net cash from / (used in) investing activities

295

295

3.

Cash flows from financing activities

885

885

3.1

Proceeds from issues of equity securities (excluding convertible debt securities)

3.2

Proceeds from issue of convertible debt securities

3.3

Proceeds from exercise of options

3.4

Transaction costs related to issues of equity securities or convertible debt securities

3.5

Proceeds from borrowings

1,462

1,462

3.6

Repayment of borrowings

(113)

(113)

3.7

Transaction costs related to loans and borrowings

3.8

Dividends paid

3.9

Other (provide details if material)

(217)

(217)

3.10

Net cash from / (used in) financing activities

2,017

2,017

4.

Net increase / (decrease) in cash and cash equivalents for the period

4.1

Cash and cash equivalents at beginning of period

464

464

4.2

Net cash from / (used in) operating activities (item 1.9 above)

(1,234)

(1,234)

4.3

Net cash from / (used in) investing activities (item 2.6 above)

295

295

4.4

Net cash from / (used in) financing activities (item 3.10 above)

2,017

2,017

4.5

Effect of movement in exchange rates on cash held

20

20

4.6

Cash and cash equivalents at end of period

1,562

 

1,562

 

 

5.

Reconciliation of cash and cash equivalentsat the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts

Current quarterUSD'000

Previous quarterUSD'000

5.1

Bank balances

3,405

3,015

5.2

Call deposits

32

33

5.3

Bank overdrafts

(1,875)

(1,267)

5.4

Other (provide details)

5.5

Cash and cash equivalents at end of quarter (should equal item 4.6 above)

1,562

1,781

 

6.

Payments to related parties of the entity and their associates

Current quarterUSD'000

6.1

Aggregate amount of payments to related parties and their associates included in item 1

6.2

Aggregate amount of payments to related parties and their associates included in item 2

Note: if any amounts are shown in items 6.1 or 6.2, your quarterly activity report must include a description of, and an explanation for, such payments.

 

7.

Financing facilitiesNote: the term "facility' includes all forms of financing arrangements available to the entity.

Add notes as necessary for an understanding of the sources of finance available to the entity.

Total facility amount at quarter endUSD'000

Amount drawn at quarter endUSD'000

7.1

Loan facilities

9,504

8,613

7.2

Credit standby arrangements

7.3

Other (please specify)

2,702

 

2,500

7.4

Total financing facilities

12,206

11,113

7.5

Unused financing facilities available at quarter end

1,093

7.6

Include in the box below a description of each facility above, including the lender, interest rate, maturity date and whether it is secured or unsecured. If any additional financing facilities have been entered into or are proposed to be entered into after quarter end, include a note providing details of those facilities as well.

USD0.9 million of the USD9.5 million provided by the Industrial Development Corporation of South Africa Limited ("IDC") to the company's subsidiary is still available for drawdown. The drawn amount plus interest is payable prior to 30 November 2020. Interest accrues at a real after tax rate of return of 16% on the advanced amount. Subsequent to the quarter end, an available amount of USD 0.9 million was drawn down at the same interest rate and is payable prior to 30 November 2020.

 

Of the USD2.7 million facility, USD1.2 million relates to the ABSA Facility that was secured during the 2019 financial year, from ABSA Bank Limited ("ABSA"). The facility is for short-term working capital requirements and potential expansion opportunities. The facility has a floating coupon at the South African Prime rate (currently 7% per annum) plus 1.0%, with the operating mine Uitkomst Colliery debtors ceded as security. The facility is subject to annual review. The short-term working facility was increased by an additional USD1.2 million in May 2020 to alleviate the financial challenges during the COVID-19 period and is secured by a general notarial bond over Uitkomst assets. This additional facility is temporary and is payable over twelve months commencing 1 July 2020 to 1 June 2021. During the period, the additional facility was reduced to $USD0.9 million due to the commencement of repayments. The same interest rate applies. $USD0.2 million of this facility was un-drawn at the end of the quarter.

 

The balance of the USD2.7 million relates to an equipment lease facility with ABSA that has been fully utilised. The lease facility has a five-year term at the South Africa prime interest rate (currently 7% per annum)

 

 

 

8.

Estimated cash available for future operating activities

USD'000

8.1

Net cash from / (used in) operating activities (item 1.9)

(1,234)

8.2

(Payments for exploration & evaluation classified as investing activities) (item 2.1(d))

(10)

8.3

Total relevant outgoings (item 8.1 + item 8.2)

(1,244)

8.4

Cash and cash equivalents at quarter end (item 4.6)

1,562

8.5

Unused finance facilities available at quarter end (item 7.5)

1,093

8.6

Total available funding (item 8.4 + item 8.5)

2,655

8.7

Estimated quarters of funding available (item 8.6 divided by item 8.3)

2

Note: if the entity has reported positive relevant outgoings (ie a net cash inflow) in item 8.3, answer item 8.7 as "N/A". Otherwise, a figure for the estimated quarters of funding available must be included in item 8.7.

8.8

If item 8.7 is less than 2 quarters, please provide answers to the following questions:

8.8.1 Does the entity expect that it will continue to have the current level of net operating cash flows for the time being and, if not, why not?

Answer: N/A

 

8.8.2 Has the entity taken any steps, or does it propose to take any steps, to raise further cash to fund its operations and, if so, what are those steps and how likely does it believe that they will be successful?

Answer: N/A

 

8.8.3 Does the entity expect to be able to continue its operations and to meet its business objectives and, if so, on what basis?

Answer: N/A

 

Note: where item 8.7 is less than 2 quarters, all of questions 8.8.1, 8.8.2 and 8.8.3 above must be answered.

 

Compliance statement

1 This statement has been prepared in accordance with accounting standards and policies which comply with Listing Rule 19.11A.

2 This statement gives a true and fair view of the matters disclosed.

 

 

Date: ...................................................................................

 

Disclosure Committee

Authorised by: ...................................................................................

(Name of body or officer authorising release - see note 4)

 

Notes

1. This quarterly cash flow report and the accompanying activity report provide a basis for informing the market about the entity's activities for the past quarter, how they have been financed and the effect this has had on its cash position. An entity that wishes to disclose additional information over and above the minimum required under the Listing Rules is encouraged to do so.

2. If this quarterly cash flow report has been prepared in accordance with Australian Accounting Standards, the definitions in, and provisions of, AASB 6: Exploration for and Evaluation of Mineral Resources and AASB 107: Statement of Cash Flows apply to this report. If this quarterly cash flow report has been prepared in accordance with other accounting standards agreed by ASX pursuant to Listing Rule 19.11A, the corresponding equivalent standards apply to this report.

3. Dividends received may be classified either as cash flows from operating activities or cash flows from investing activities, depending on the accounting policy of the entity.

4. If this report has been authorised for release to the market by your board of directors, you can insert here: "By the board". If it has been authorised for release to the market by a committee of your board of directors, you can insert here: "By the [name of board committee - eg Audit and Risk Committee]". If it has been authorised for release to the market by a disclosure committee, you can insert here: "By the Disclosure Committee".

5. If this report has been authorised for release to the market by your board of directors and you wish to hold yourself out as complying with recommendation 4.2 of the ASX Corporate Governance Council's Corporate Governance Principles and Recommendations, the board should have received a declaration from its CEO and CFO that, in their opinion, the financial records of the entity have been properly maintained, that this report complies with the appropriate accounting standards and gives a true and fair view of the cash flows of the entity, and that their opinion has been formed on the basis of a sound system of risk management and internal control which is operating effectively.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDPPGRWUUPUGMB
Date   Source Headline
28th Mar 20247:00 amRNSGoldway - Fourth supplementary bidder's statement
25th Mar 20248:49 amRNSResponse to 3rd Supplementary Bidder's Statement
22nd Mar 20247:00 amRNSGoldway Capital Investment - Status of Conditions
22nd Mar 20247:00 amRNSChange in substantial holding
21st Mar 20247:00 amRNSGoldway - Third supplementary bidder's statement
20th Mar 20241:01 pmRNSResponse to 2nd Supplementary Bidder's Statement
19th Mar 20247:01 amRNSChange in substantial holding
18th Mar 20247:33 amRNSSupplementary Target's Statement - DO NOT ACCEPT
15th Mar 202410:15 amRNSInterim Financial Report
15th Mar 20249:41 amRNSHalf-year Results
14th Mar 20249:51 amRNSSecond Bidder's Statement - Do Not Accept
12th Mar 20247:19 amRNSOffer Update
8th Mar 20249:31 amRNSNon-Binding Indicative Offer from Vulcan Resources
4th Mar 20247:00 amRNSChange in substantial holding
4th Mar 20247:00 amRNSRelease of Target Statement
19th Feb 20247:00 amRNSGoldway Capital - Dispatch of Bidder's Statement
15th Feb 20248:04 amRNSOff-Market Takeover Bid - Do NOT Accept the Offer
15th Feb 20247:00 amRNSGoldway Capital - Supplementary Bidder's Statement
2nd Feb 202411:30 amRNSTakeover Bid - Receipt of Bidder's Statement
2nd Feb 20247:00 amRNSGoldway Capital Investment - Bidder's Statement
31st Jan 20248:45 amRNSAppendix 5B
31st Jan 20248:40 amRNSActivities Report for the Quarter ended 31 Dec 23
24th Jan 20249:30 amRNSNon-Binding and Indicative Proposal Update
22nd Dec 20238:32 amRNSNon-Binding and Indicative Proposal Update
22nd Dec 20237:30 amRNSOperations & Trading Update
18th Dec 20233:30 pmRNSDirector/PDMR Shareholding
18th Dec 20233:02 pmRNSREVISED NON-BINDING AND INDICATIVE PROPOSAL
30th Nov 20232:31 pmRNSResult of Annual General Meeting
27th Nov 20233:03 pmRNSAnnual General Meeting Details
8th Nov 20237:15 amRNSIssue of Equity
2nd Nov 20231:15 pmRNSReceipt of Notice of Intention to Make a Takeover
31st Oct 20232:30 pmRNSDespatch of Annual Report and Notice of AGM
31st Oct 20239:25 amRNSActivities Report for the Quarter Ended 30 Sep 23
31st Oct 20239:25 amRNSAppendix 5B
27th Oct 202310:30 amRNSIssue of Equity
5th Oct 202310:30 amRNSAnnual General Meeting Details
21st Sep 202312:13 pmRNSResults for the Full Year Ended 30 June 2023
15th Sep 202310:10 amRNSChange of Australian Share Registry Address
31st Jul 20239:35 amRNSAppendix 5B
31st Jul 20239:33 amRNSACTIVITIES REPORT FOR QUARTER ENDED 30 JUNE 2023
25th Jul 20237:45 amRNSIDC Extension Announcement
30th Jun 202312:15 pmRNSTrading Update
28th Apr 20239:35 amRNSAppendix 5B
28th Apr 20239:30 amRNSActivities Report for the Quarter Ended 31 Mar 23
27th Apr 20239:00 amRNSHolding(s) in Company
26th Apr 202311:20 amRNSMakhado Project Update
31st Mar 20238:02 amRNSIssue of Shares Under the Performance Rights Plan
16th Mar 20237:00 amRNSChange of JSE Sponsor
15th Mar 20237:40 amRNSInterim Financial Report
15th Mar 20237:40 amRNSHalf-year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.